Regentis Biomaterials Ltd. Operating Cash Flow
Regentis Biomaterials Ltd. (RGNT) reported Operating Cash Flow of -$1.38 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-02-27
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2025-12-31 | -$1.38M 20-F/A · filed 2026-02-27 |
| 2024-12-31 | -$641.00K 20-F/A · filed 2026-02-27 |
| 2023-12-31 | -$1.22M 20-F/A · filed 2026-02-27 |